A team led by researchers at the School of Medicine in St. Louis has identified a pair of genes that influence risk for Alzheimer’s disease. The genes — known as MS4A4A and TREM2 — affect the brain’s immune cells. They influence Alzheimer’s risk by altering levels of TREM2, a protein that is believed to help microglia cells clear excessive amounts of the Alzheimer’s proteins amyloid and tau from the brain.
Researchers at the School of Medicine have found the molecular signature of a healthy gut microbial community – the kind that can keep the intestinal bacteria Clostridium difficile (C. difficile) from overgrowing and causing diarrhea.
A blood test to detect the brain changes of early Alzheimer’s disease has moved one step closer to reality. Researchers from the School of Medicine report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain.
Physicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have been awarded a six-year, $7.8 million grant from the National Cancer Institute (NCI) to play a leading role in designing, conducting and enrolling patients in clinical trials through the NCI’s National Clinical Trials Network.
A study of the genetics of the people of Finland, conducted in part by researchers at the School of Medicine, has revealed new clues to common diseases.
Researchers at the School of Medicine have found that Enhanced Medical Rehabilitation, a type of goal-oriented therapy, helps older patients recover more fully than standard physical or occupational therapy. It involves focusing on specific goals important to individual patients and motivating patients to work toward those goals during every therapy session.
Bacteria in the bloodstream can trigger an overwhelming immune response that causes sepsis, a life-threatening condition. Now, researchers at Washington University School of Medicine in St. Louis have found genes that help protect the body’s cells from dying during sepsis, which could lead to new treatments.
A new program funded through the Cancer Moonshot Initiative has doubled the number of patients at Siteman Cancer Center assessed for smoking — and increased by fivefold the percentage of cancer patients who smoke now taking medication to help them quit. The results have been published in the journal Translational Behavioral Medicine.
Researchers at the School of Medicine and the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, are developing a new approach to address childhood malnutrition. They are designing therapeutic foods aimed at repairing the gut microbiomes of malnourished children.
Researchers at the School of Medicine in St. Louis and Rush University in Chicago have found a compound that promotes a vigorous immune assault on pancreatic cancer. The findings, in mice, suggest a way to improve immunotherapy for the deadly disease in patients.